Decode Age raises $1.7 Mn in pre-Series A round

Bengaluru-based longevity science startup Decode Age has raised Rs 14.48 crore (around $1.7 million) in a pre-Series A round led by Krishna Prasad Chigurupati, chairman and managing director of Granules India.

Founded in 2021, Decode Age works at the intersection of aging biology, biomarkers, and gut microbiome science. The company focuses on making ageing-related biological signals measurable and usable through testing, research, and precision-led interventions.

The proceeds will be used to expand Decode Age’s biomarker discovery programmes, strengthen its multi-omics and microbiome research pipeline, and upgrade scientific and analytical infrastructure. 

The firm is also working on research-backed supplements and longevity solutions linked to aging pathways such as metabolism, inflammation, cellular energy, and cognitive health.

Decode Age has built an in-house platform covering genome-scale gut microbiome analysis, metagenomics, and biomarker research. Its systems are designed to support clinicians, researchers, and individuals seeking data-driven insights into long-term health and aging.

The startup is also expanding its scientific and product teams as it looks to take its longevity research beyond India. It collaborates with academic and global research initiatives, including work linked to IISc and international longevity programmes, to generate microbiome and ageing data aligned with global research standards.